{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:39:53Z","timestamp":1792625993869,"version":"4.5.0"},"reference-count":38,"publisher":"MyJove Corporation","issue":"159","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/60873","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:33:08Z","timestamp":1590139988000},"source":"Crossref","is-referenced-by-count":0,"title":["Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against &lt;em&gt;Bacillus anthracis&lt;\/em&gt; and Other Encapsulated Pathogens"],"prefix":"10.3791","author":[{"given":"Jennifer","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald  J.","family":"Chabot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Putmon-Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur  M.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10408447809081012","type":"journal-article","article-title":"Phagocytosis: a review","volume":"5","author":"Walters","year":"1978","unstructured":"Walters, M. N., Papadimitriou, J. M. Phagocytosis: a review. CRC Critical Reviews in Toxicology. 5 (4), 377-421 (1978).","journal-title":"CRC Critical Reviews in Toxicology"},{"key":"ref2","first-page":"144","type":"journal-article","article-title":"Untersuchurgen uber die intracellulare Verdauung, bei wirbellosen Thieren","volume":"5","author":"Metschnikoff","year":"1883","unstructured":"Metschnikoff, E. Untersuchurgen uber die intracellulare Verdauung, bei wirbellosen Thieren. Arbeiten aus dem Zoologischen Instituten der Universit\u00e4t Wien. 5, 144 (1883).","journal-title":"Arbeiten aus dem Zoologischen Instituten der Universit\u00e4t Wien"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1244","type":"journal-article","article-title":"Metchnikoff and the phagocytosis theory","volume":"4","author":"Tauber","year":"2003","unstructured":"Tauber, A. I. Metchnikoff and the phagocytosis theory. Nature Reviews Molecular Cell Biology. 4 (11), 897-901 (2003).","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0167-5699(92)90198-G","type":"journal-article","article-title":"The immune system evolved to discriminate infectious nonself from noninfectious self","volume":"13","author":"Janeway","year":"1992","unstructured":"Janeway, C. A., Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology Today. 13 (1), 11-16 (1992).","journal-title":"Immunology Today"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2010.01.058","type":"journal-article","article-title":"Identification and functions of pattern-recognition receptors","volume":"125","author":"Kumagai","year":"2010","unstructured":"Kumagai, Y., Akira, S. Identification and functions of pattern-recognition receptors. Journal of Allergy and Clinical Immunology. 125 (5), 985-992 (2010).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pathol-011811-132445","type":"journal-article","article-title":"The cell biology of phagocytosis","volume":"7","author":"Flannagan","year":"2012","unstructured":"Flannagan, R. S., Jaumouille, V., Grinstein, S. The cell biology of phagocytosis. Annual Review of Pathology. 7, 61-98 (2012).","journal-title":"Annual Review of Pathology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2958.2006.05179.x","type":"journal-article","article-title":"Poly-gamma-glutamate in bacteria","volume":"60","author":"Candela","year":"2006","unstructured":"Candela, T., Fouet, A. Poly-gamma-glutamate in bacteria. Molecular Microbiology. 60 (5), 1091-1098 (2006).","journal-title":"Molecular Microbiology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1172\/JCI200523523","type":"journal-article","article-title":"Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis","volume":"115","author":"Kocianova","year":"2005","unstructured":"Kocianova, S. et al. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. Journal of Clinical Investigation. 115 (3), 688-694 (2005).","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.88.3.325","type":"journal-article","article-title":"Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A Streptococcus infection in mice","volume":"88","author":"Rothbard","year":"1948","unstructured":"Rothbard, S. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A Streptococcus infection in mice. Journal of Experimental Medicine. 88 (3), 325-342 (1948).","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2958.2011.07582.x","type":"journal-article","article-title":"Two capsular polysaccharides enable Bacillus cereus G9241 to cause anthrax-like disease","volume":"80","author":"Oh","year":"2011","unstructured":"Oh, S. Y., Budzik, J. M., Garufi, G., Schneewind, O. Two capsular polysaccharides enable Bacillus cereus G9241 to cause anthrax-like disease. Molecular Microbiology. 80 (2), 455-470 (2011).","journal-title":"Molecular Microbiology"},{"issue":"31","key":"ref11","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","type":"journal-article","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","unstructured":"Knuf, M., Kowalzik, F., Kieninger, D. Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine. 29 (31), 4881-4890 (2011).","journal-title":"Vaccine"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/IAI.72.9.5460-5463.2004","type":"journal-article","article-title":"The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen","volume":"72","author":"Wang","year":"2004","unstructured":"Wang, T. T., Lucas, A. H. The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen. Infection & Immunity. 72 (9), 5460-5463 (2004).","journal-title":"Infection & Immunity"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/cdli.1.4.394-400.1994","type":"journal-article","article-title":"Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes","volume":"1","author":"Vogel","year":"1994","unstructured":"Vogel, L. et al. Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes. Clinical and Diagnostic Laboratory Immunology. 1 (4), 394-400 (1994).","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"00617","DOI":"10.1128\/mSphere.00617-18","type":"journal-article","article-title":"Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes","volume":"3","author":"Salehi","year":"2018","unstructured":"Salehi, S., Hohn, C. M., Penfound, T. A., Dale, J. B. Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes. mSphere. 3 (6), e00617-18 (2018).","journal-title":"mSphere"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00423-18","type":"journal-article","article-title":"Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen","volume":"86","author":"Wang","year":"2018","unstructured":"Wang, Y. et al. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen. Infection & Immunity. 86 (9) (2018).","journal-title":"Infection & Immunity"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CVI.00100-15","type":"journal-article","article-title":"Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England","volume":"22","author":"Humphries","year":"2015","unstructured":"Humphries, H. E. et al. Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England. Clinical and Vaccine Immunology. 22 (5), 503-509 (2015).","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref17","volume-title":"List of Tier 1 BSAT","year":"2017","unstructured":"List of Tier 1 BSAT. www.selectagents.gov\/ohp-app1.html (2017)."},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CDLI.5.5.703-710.1998","type":"journal-article","article-title":"Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies","volume":"5","author":"Jansen","year":"1998","unstructured":"Jansen, W. T. et al. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clinical and Diagnostic Laboratory Immunology. 5 (5), 703-710 (1998).","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-8244(03)00366-3","type":"journal-article","article-title":"Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate","volume":"40","author":"Wang","year":"2004","unstructured":"Wang, T. T., Fellows, P. F., Leighton, T. J., Lucas, A. H. Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. FEMS Immunology and Medical Microbiology. 40 (3), 231-237 (2004).","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"34","key":"ref20","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1016\/j.vaccine.2016.06.031","type":"journal-article","article-title":"Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine","volume":"34","author":"Chabot","year":"2016","unstructured":"Chabot, D. J. et al. Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine. Vaccine. 34 (34), 4012-4016 (2016).","journal-title":"Vaccine"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.vaccine.2011.12.010","type":"journal-article","article-title":"Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys","volume":"30","author":"Chabot","year":"2012","unstructured":"Chabot, D. J. et al. Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys. Vaccine. 30 (5), 846-852 (2012).","journal-title":"Vaccine"},{"key":"ref22","volume-title":"Revised FSAP Policy Statement: Inactivated Bacillus anthracis and Bacillus cereus Biovar anthracis","year":"2017","unstructured":"Revised FSAP Policy Statement: Inactivated Bacillus anthracis and Bacillus cereus Biovar anthracis. www.selectagents.gov\/policystatement_bacillus.html (2017)."},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3201\/eid2505.180928","type":"journal-article","article-title":"Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues","volume":"25","author":"Chua","year":"2019","unstructured":"Chua, J. et al. Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues. Emerging Infectious Diseases. 25 (5), 919-926 (2019).","journal-title":"Emerging Infectious Diseases"},{"key":"ref24","volume-title":"Guide for the Care and Use of Laboratory Animals (Eighth Edition)","year":"2011","unstructured":"Guide for the Care and Use of Laboratory Animals (Eighth Edition). https:\/\/www.aaalac.org; https:\/\/grants.nih.gov\/grants\/olaw\/guide-for-the-care-and-use-of-laboratory-animals.pdf (2011)."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12320","type":"journal-article","article-title":"Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults","volume":"19","author":"Durando","year":"2013","unstructured":"Durando, P. et al. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clinical Microbiology and Infection. 19 Suppl 1, 1-9 (2013).","journal-title":"Clinical Microbiology and Infection"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.1993.03500020055031","type":"journal-article","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","unstructured":"Adams, W. G. et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 269 (2), 221-226 (1993).","journal-title":"JAMA"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","type":"journal-article","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","unstructured":"Balmer, P., Borrow, R., Miller, E. Impact of meningococcal C conjugate vaccine in the UK. Journal of Medical Microbiology. 51 (9), 717-722 (2002).","journal-title":"Journal of Medical Microbiology"},{"issue":"38","key":"ref28","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1016\/j.vaccine.2008.06.093","type":"journal-article","article-title":"Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults","volume":"26","author":"Chen","year":"2008","unstructured":"Chen, M. et al. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults. Vaccine. 26 (38), 4962-4968 (2008).","journal-title":"Vaccine"},{"issue":"146","key":"ref29","first-page":"e59400","type":"journal-article","article-title":"Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens","author":"Paschall","year":"2019","unstructured":"Paschall, A. V., Middleton, D. R., Avci, F. Y. Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens. Journal of Visualized Experiments. (146) 59400 (2019).","journal-title":"Journal of Visualized Experiments"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2672.1999.00881.x","type":"journal-article","article-title":"The capsule of Bacillus anthracis, a review","volume":"87","author":"Ezzell","year":"1999","unstructured":"Ezzell, J. W., Welkos, S. L. The capsule of Bacillus anthracis, a review. Journal of Applied Microbiology. 87 (2), 250 (1999).","journal-title":"Journal of Applied Microbiology"},{"issue":"21","key":"ref31","first-page":"10198","type":"journal-article","article-title":"On the role of macrophages in anthrax","volume":"90","author":"Hanna","year":"1993","unstructured":"Hanna, P. C., Acosta, D., Collier, R. J. On the role of macrophages in anthrax. Proceedings of the National Academies of Sciences of the United States of America. 90 (21), 10198-10201 (1993).","journal-title":"Proceedings of the National Academies of Sciences of the United States of America"},{"issue":"1","key":"ref32","first-page":"19","type":"journal-article","article-title":"Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies","volume":"12","author":"Fleck","year":"2005","unstructured":"Fleck, R. A., Romero-Steiner, S., Nahm, M. H. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clinical and Diagnostic Laboratory Immunology. 12 (1), 19-27 (2005).","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"35","key":"ref33","doi-asserted-by":"crossref","first-page":"36982","DOI":"10.1074\/jbc.M405082200","type":"journal-article","article-title":"Mycobacterium tuberculosis reprograms waves of phosphatidylinositol 3-phosphate on phagosomal organelles","volume":"279","author":"Chua","year":"2004","unstructured":"Chua, J., Deretic, V. Mycobacterium tuberculosis reprograms waves of phosphatidylinositol 3-phosphate on phagosomal organelles. Journal of Biological Chemistry. 279 (35), 36982-36992 (2004).","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00586-16","type":"journal-article","article-title":"pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells","volume":"85","author":"Chua","year":"2017","unstructured":"Chua, J. et al. pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells. Infection & Immunity. 85 (1), (2017).","journal-title":"Infection & Immunity"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","type":"journal-article","article-title":"Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies","volume":"13","author":"Ober","year":"2001","unstructured":"Ober, R. J., Radu, C. G., Ghetie, V., Ward, E. S. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. International Immunology. 13 (12), 1551-1559 (2001).","journal-title":"International Immunology"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","type":"journal-article","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"Sorman","year":"2014","unstructured":"Sorman, A., Zhang, L., Ding, Z., Heyman, B. How antibodies use complement to regulate antibody responses. Molecular Immunology. 61 (2), 79-88 (2014).","journal-title":"Molecular Immunology"},{"issue":"13","key":"ref37","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","type":"journal-article","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children","volume":"25","author":"Henckaerts","year":"2007","unstructured":"Henckaerts, I., Durant, N., De Grave, D., Schuerman, L., Poolman, J. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine. 25 (13), 2518-2527 (2007).","journal-title":"Vaccine"},{"key":"ref38","type":"book","volume-title":"Special Considerations for the Nonclinical Safety Assessment of Vaccines","author":"Wolf","year":"2013","unstructured":"Wolf, J. J. Special Considerations for the Nonclinical Safety Assessment of Vaccines. 243-255 Elsevier, (2013)."}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/60873\/opsono-adherence-assay-to-evaluate-functional-antibodies-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:55Z","timestamp":1792624015000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/60873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":38,"journal-issue":{"issue":"159","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3791\/60873","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]}}}